Abo Bibliothek: Guest
Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen
Critical Reviews™ in Eukaryotic Gene Expression
Impact-faktor: 1.841 5-jähriger Impact-Faktor: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Druckformat: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2015013843
pages 203-207

Dual Protective and Cytotoxic Benefits of Mesenchymal Stem Cell Therapy in Combination with Chemotherapy/Radiotherapy for Cancer Patients

Fatemeh Hendijani
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran
Shaghayegh Haghjooy Javanmard
Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

ABSTRAKT

Cancer is a major health problem in the world, and scientists seek innovative treatment strategies with higher efficacy and lower toxicity than the existing therapeutic agents. In this way, stem cell researchers try to reveal new pathways that will eventually benefit patients. Stem cell research has proven that mesenchymal stem cells (MSCs) possess anticancer activities, and their protein-rich secretome showed similar effects. MSCs also secrete cytokines that play an active role in healing and regeneration processes. Because of their known plasticity, MSCs display a variety of characteristics and functions in different environments, depending on their interactions with various cell types and tissues. Therefore, we hypothesize that MSC therapy in combination with anticancer medicines can potentiate cytotoxic effects on cancer cells. In addition, because of their regenerative capacity, MSCs can protect normal tissues from adverse cytotoxic drug reactions. They may also help rescue injured tissues from these toxic damages or systemic pathological events that occur during cancer treatment. MSC therapy may double the beneficial effects on cancer and normal cells. As our knowledge of systems biology and biotechnological methodology is progressing, this idea can move forward as a treatment option.


Articles with similar content:

Programming hMSCs into Potential Genetic Therapy in Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 4
Nedime Serakinci, Huseyin Cagsin
Modulation of Intracellular Signaling Using Protein-Transduction Technology
Critical Reviews™ in Immunology, Vol.30, 2010, issue 5
Nao Jounai, Akihide Ryo, Toshihiro Horii, Ken J. Ishii, Koichi Suzuki, Kouji Kobiyama, Fumihiko Takeshita
Regenerative Dental Medicine: Stem Cells and Tissue Engineering in Dentistry
Journal of Environmental Pathology, Toxicology and Oncology, Vol.25, 2006, issue 3
Jill A. Reed, Roberto Patarca
Functional Properties of Human Embryonic Stem Cell−Derived Cardiomyocytes
Critical Reviews™ in Eukaryotic Gene Expression, Vol.20, 2010, issue 1
Naama Zeevi-Levin, Ofer Binah, Joseph Itskovitz-Eldor
Gain of Antitumor Functions and Induction of Differentiation in Cancer Stem Cells Contribute to Complete Cure and No Relapse
Critical Reviews™ in Oncogenesis, Vol.15, 2009, issue 1-2
Minal Garg